Clinical Trial Update: CKD-330 Drug-Drug Interaction Study (Candesartan) [Phase 1]

View source ↗

Summary

The study reports the completion of a phase 1 drug-drug interaction trial evaluating CKD-330 with candesartan in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-330
• Candesartan (candesartan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 1 | Status: COMPLETED